Medical Care
Global Small Molecule CDMO Market Research Report 2025
- Jun 28, 25
- ID: 346303
- Pages: 106
- Figures: 110
- Views: 1
The global market for Small Molecule CDMO was valued at US$ 1388 million in the year 2024 and is projected to reach a revised size of US$ 2944 million by 2031, growing at a CAGR of 11.5% during the forecast period.
North American market for Small Molecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Molecule CDMO in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type
Development
API Production
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Small Molecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Molecule CDMO in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type
Development
API Production
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Development
1.2.3 API Production
1.3 Market by Application
1.3.1 Global Small Molecule CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CDMO Market Perspective (2020-2031)
2.2 Global Small Molecule CDMO Growth Trends by Region
2.2.1 Global Small Molecule CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule CDMO Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule CDMO Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule CDMO Market Dynamics
2.3.1 Small Molecule CDMO Industry Trends
2.3.2 Small Molecule CDMO Market Drivers
2.3.3 Small Molecule CDMO Market Challenges
2.3.4 Small Molecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule CDMO Players by Revenue
3.1.1 Global Top Small Molecule CDMO Players by Revenue (2020-2025)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule CDMO Revenue
3.4 Global Small Molecule CDMO Market Concentration Ratio
3.4.1 Global Small Molecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CDMO Revenue in 2024
3.5 Global Key Players of Small Molecule CDMO Head office and Area Served
3.6 Global Key Players of Small Molecule CDMO, Product and Application
3.7 Global Key Players of Small Molecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CDMO Breakdown Data by Type
4.1 Global Small Molecule CDMO Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule CDMO Forecasted Market Size by Type (2026-2031)
5 Small Molecule CDMO Breakdown Data by Application
5.1 Global Small Molecule CDMO Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule CDMO Market Size (2020-2031)
6.2 North America Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule CDMO Market Size by Country (2020-2025)
6.4 North America Small Molecule CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule CDMO Market Size (2020-2031)
7.2 Europe Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule CDMO Market Size by Country (2020-2025)
7.4 Europe Small Molecule CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule CDMO Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule CDMO Market Size (2020-2031)
9.2 Latin America Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule CDMO Market Size by Country (2020-2025)
9.4 Latin America Small Molecule CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule CDMO Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule CDMO Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Small Molecule CDMO Introduction
11.3.4 Thermo Fisher Revenue in Small Molecule CDMO Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Details
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CDMO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CDMO Business (2020-2025)
11.4.5 Wuxi Apptec Recent Development
11.5 PharmaBlock
11.5.1 PharmaBlock Company Details
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CDMO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CDMO Business (2020-2025)
11.5.5 PharmaBlock Recent Development
11.6 Asym Chemical
11.6.1 Asym Chemical Company Details
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CDMO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CDMO Business (2020-2025)
11.6.5 Asym Chemical Recent Development
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Details
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2020-2025)
11.7.5 Jiuzhou Pharmaceutical Recent Development
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Details
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CDMO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CDMO Business (2020-2025)
11.8.5 Pharmaron Beijing Recent Development
11.9 Porton Pharma
11.9.1 Porton Pharma Company Details
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CDMO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CDMO Business (2020-2025)
11.9.5 Porton Pharma Recent Development
11.10 ChemPartner
11.10.1 ChemPartner Company Details
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CDMO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CDMO Business (2020-2025)
11.10.5 ChemPartner Recent Development
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Details
11.11.2 Jiangsu Sinopep Business Overview
11.11.3 Jiangsu Sinopep Small Molecule CDMO Introduction
11.11.4 Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2020-2025)
11.11.5 Jiangsu Sinopep Recent Development
11.12 DELPHARM
11.12.1 DELPHARM Company Details
11.12.2 DELPHARM Business Overview
11.12.3 DELPHARM Small Molecule CDMO Introduction
11.12.4 DELPHARM Revenue in Small Molecule CDMO Business (2020-2025)
11.12.5 DELPHARM Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Small Molecule CDMO Introduction
11.13.4 Aenova Group Revenue in Small Molecule CDMO Business (2020-2025)
11.13.5 Aenova Group Recent Development
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Details
11.14.2 Siegfried Holding AG Business Overview
11.14.3 Siegfried Holding AG Small Molecule CDMO Introduction
11.14.4 Siegfried Holding AG Revenue in Small Molecule CDMO Business (2020-2025)
11.14.5 Siegfried Holding AG Recent Development
11.15 Recipharm AB
11.15.1 Recipharm AB Company Details
11.15.2 Recipharm AB Business Overview
11.15.3 Recipharm AB Small Molecule CDMO Introduction
11.15.4 Recipharm AB Revenue in Small Molecule CDMO Business (2020-2025)
11.15.5 Recipharm AB Recent Development
11.16 FAREVA SA
11.16.1 FAREVA SA Company Details
11.16.2 FAREVA SA Business Overview
11.16.3 FAREVA SA Small Molecule CDMO Introduction
11.16.4 FAREVA SA Revenue in Small Molecule CDMO Business (2020-2025)
11.16.5 FAREVA SA Recent Development
11.17 Almac Group
11.17.1 Almac Group Company Details
11.17.2 Almac Group Business Overview
11.17.3 Almac Group Small Molecule CDMO Introduction
11.17.4 Almac Group Revenue in Small Molecule CDMO Business (2020-2025)
11.17.5 Almac Group Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Details
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Small Molecule CDMO Introduction
11.18.4 Cambrex Revenue in Small Molecule CDMO Business (2020-2025)
11.18.5 Cambrex Recent Development
11.19 Charles River
11.19.1 Charles River Company Details
11.19.2 Charles River Business Overview
11.19.3 Charles River Small Molecule CDMO Introduction
11.19.4 Charles River Revenue in Small Molecule CDMO Business (2020-2025)
11.19.5 Charles River Recent Development
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Details
11.20.2 CORDEN PHARMA Business Overview
11.20.3 CORDEN PHARMA Small Molecule CDMO Introduction
11.20.4 CORDEN PHARMA Revenue in Small Molecule CDMO Business (2020-2025)
11.20.5 CORDEN PHARMA Recent Development
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Details
11.21.2 Jubilant Pharmova Business Overview
11.21.3 Jubilant Pharmova Small Molecule CDMO Introduction
11.21.4 Jubilant Pharmova Revenue in Small Molecule CDMO Business (2020-2025)
11.21.5 Jubilant Pharmova Recent Development
11.22 Consort Medical
11.22.1 Consort Medical Company Details
11.22.2 Consort Medical Business Overview
11.22.3 Consort Medical Small Molecule CDMO Introduction
11.22.4 Consort Medical Revenue in Small Molecule CDMO Business (2020-2025)
11.22.5 Consort Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Development
1.2.3 API Production
1.3 Market by Application
1.3.1 Global Small Molecule CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CDMO Market Perspective (2020-2031)
2.2 Global Small Molecule CDMO Growth Trends by Region
2.2.1 Global Small Molecule CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule CDMO Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule CDMO Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule CDMO Market Dynamics
2.3.1 Small Molecule CDMO Industry Trends
2.3.2 Small Molecule CDMO Market Drivers
2.3.3 Small Molecule CDMO Market Challenges
2.3.4 Small Molecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule CDMO Players by Revenue
3.1.1 Global Top Small Molecule CDMO Players by Revenue (2020-2025)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule CDMO Revenue
3.4 Global Small Molecule CDMO Market Concentration Ratio
3.4.1 Global Small Molecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CDMO Revenue in 2024
3.5 Global Key Players of Small Molecule CDMO Head office and Area Served
3.6 Global Key Players of Small Molecule CDMO, Product and Application
3.7 Global Key Players of Small Molecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CDMO Breakdown Data by Type
4.1 Global Small Molecule CDMO Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule CDMO Forecasted Market Size by Type (2026-2031)
5 Small Molecule CDMO Breakdown Data by Application
5.1 Global Small Molecule CDMO Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule CDMO Market Size (2020-2031)
6.2 North America Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule CDMO Market Size by Country (2020-2025)
6.4 North America Small Molecule CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule CDMO Market Size (2020-2031)
7.2 Europe Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule CDMO Market Size by Country (2020-2025)
7.4 Europe Small Molecule CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule CDMO Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule CDMO Market Size (2020-2031)
9.2 Latin America Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule CDMO Market Size by Country (2020-2025)
9.4 Latin America Small Molecule CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule CDMO Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule CDMO Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Small Molecule CDMO Introduction
11.3.4 Thermo Fisher Revenue in Small Molecule CDMO Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Details
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CDMO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CDMO Business (2020-2025)
11.4.5 Wuxi Apptec Recent Development
11.5 PharmaBlock
11.5.1 PharmaBlock Company Details
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CDMO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CDMO Business (2020-2025)
11.5.5 PharmaBlock Recent Development
11.6 Asym Chemical
11.6.1 Asym Chemical Company Details
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CDMO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CDMO Business (2020-2025)
11.6.5 Asym Chemical Recent Development
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Details
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2020-2025)
11.7.5 Jiuzhou Pharmaceutical Recent Development
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Details
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CDMO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CDMO Business (2020-2025)
11.8.5 Pharmaron Beijing Recent Development
11.9 Porton Pharma
11.9.1 Porton Pharma Company Details
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CDMO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CDMO Business (2020-2025)
11.9.5 Porton Pharma Recent Development
11.10 ChemPartner
11.10.1 ChemPartner Company Details
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CDMO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CDMO Business (2020-2025)
11.10.5 ChemPartner Recent Development
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Details
11.11.2 Jiangsu Sinopep Business Overview
11.11.3 Jiangsu Sinopep Small Molecule CDMO Introduction
11.11.4 Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2020-2025)
11.11.5 Jiangsu Sinopep Recent Development
11.12 DELPHARM
11.12.1 DELPHARM Company Details
11.12.2 DELPHARM Business Overview
11.12.3 DELPHARM Small Molecule CDMO Introduction
11.12.4 DELPHARM Revenue in Small Molecule CDMO Business (2020-2025)
11.12.5 DELPHARM Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Small Molecule CDMO Introduction
11.13.4 Aenova Group Revenue in Small Molecule CDMO Business (2020-2025)
11.13.5 Aenova Group Recent Development
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Details
11.14.2 Siegfried Holding AG Business Overview
11.14.3 Siegfried Holding AG Small Molecule CDMO Introduction
11.14.4 Siegfried Holding AG Revenue in Small Molecule CDMO Business (2020-2025)
11.14.5 Siegfried Holding AG Recent Development
11.15 Recipharm AB
11.15.1 Recipharm AB Company Details
11.15.2 Recipharm AB Business Overview
11.15.3 Recipharm AB Small Molecule CDMO Introduction
11.15.4 Recipharm AB Revenue in Small Molecule CDMO Business (2020-2025)
11.15.5 Recipharm AB Recent Development
11.16 FAREVA SA
11.16.1 FAREVA SA Company Details
11.16.2 FAREVA SA Business Overview
11.16.3 FAREVA SA Small Molecule CDMO Introduction
11.16.4 FAREVA SA Revenue in Small Molecule CDMO Business (2020-2025)
11.16.5 FAREVA SA Recent Development
11.17 Almac Group
11.17.1 Almac Group Company Details
11.17.2 Almac Group Business Overview
11.17.3 Almac Group Small Molecule CDMO Introduction
11.17.4 Almac Group Revenue in Small Molecule CDMO Business (2020-2025)
11.17.5 Almac Group Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Details
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Small Molecule CDMO Introduction
11.18.4 Cambrex Revenue in Small Molecule CDMO Business (2020-2025)
11.18.5 Cambrex Recent Development
11.19 Charles River
11.19.1 Charles River Company Details
11.19.2 Charles River Business Overview
11.19.3 Charles River Small Molecule CDMO Introduction
11.19.4 Charles River Revenue in Small Molecule CDMO Business (2020-2025)
11.19.5 Charles River Recent Development
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Details
11.20.2 CORDEN PHARMA Business Overview
11.20.3 CORDEN PHARMA Small Molecule CDMO Introduction
11.20.4 CORDEN PHARMA Revenue in Small Molecule CDMO Business (2020-2025)
11.20.5 CORDEN PHARMA Recent Development
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Details
11.21.2 Jubilant Pharmova Business Overview
11.21.3 Jubilant Pharmova Small Molecule CDMO Introduction
11.21.4 Jubilant Pharmova Revenue in Small Molecule CDMO Business (2020-2025)
11.21.5 Jubilant Pharmova Recent Development
11.22 Consort Medical
11.22.1 Consort Medical Company Details
11.22.2 Consort Medical Business Overview
11.22.3 Consort Medical Small Molecule CDMO Introduction
11.22.4 Consort Medical Revenue in Small Molecule CDMO Business (2020-2025)
11.22.5 Consort Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Molecule CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Development
Table 3. Key Players of API Production
Table 4. Global Small Molecule CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Molecule CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Molecule CDMO Market Share by Region (2020-2025)
Table 8. Global Small Molecule CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Molecule CDMO Market Share by Region (2026-2031)
Table 10. Small Molecule CDMO Market Trends
Table 11. Small Molecule CDMO Market Drivers
Table 12. Small Molecule CDMO Market Challenges
Table 13. Small Molecule CDMO Market Restraints
Table 14. Global Small Molecule CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Molecule CDMO Market Share by Players (2020-2025)
Table 16. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2024)
Table 17. Ranking of Global Top Small Molecule CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Molecule CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Molecule CDMO, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule CDMO, Product and Application
Table 21. Global Key Players of Small Molecule CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Molecule CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Small Molecule CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Molecule CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Small Molecule CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Molecule CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Small Molecule CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Molecule CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Molecule CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Molecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Molecule CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza Small Molecule CDMO Product
Table 49. Lonza Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Details
Table 52. Catalent Business Overview
Table 53. Catalent Small Molecule CDMO Product
Table 54. Catalent Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Thermo Fisher Company Details
Table 57. Thermo Fisher Business Overview
Table 58. Thermo Fisher Small Molecule CDMO Product
Table 59. Thermo Fisher Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Recent Development
Table 61. Wuxi Apptec Company Details
Table 62. Wuxi Apptec Business Overview
Table 63. Wuxi Apptec Small Molecule CDMO Product
Table 64. Wuxi Apptec Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 65. Wuxi Apptec Recent Development
Table 66. PharmaBlock Company Details
Table 67. PharmaBlock Business Overview
Table 68. PharmaBlock Small Molecule CDMO Product
Table 69. PharmaBlock Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 70. PharmaBlock Recent Development
Table 71. Asym Chemical Company Details
Table 72. Asym Chemical Business Overview
Table 73. Asym Chemical Small Molecule CDMO Product
Table 74. Asym Chemical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 75. Asym Chemical Recent Development
Table 76. Jiuzhou Pharmaceutical Company Details
Table 77. Jiuzhou Pharmaceutical Business Overview
Table 78. Jiuzhou Pharmaceutical Small Molecule CDMO Product
Table 79. Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 80. Jiuzhou Pharmaceutical Recent Development
Table 81. Pharmaron Beijing Company Details
Table 82. Pharmaron Beijing Business Overview
Table 83. Pharmaron Beijing Small Molecule CDMO Product
Table 84. Pharmaron Beijing Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 85. Pharmaron Beijing Recent Development
Table 86. Porton Pharma Company Details
Table 87. Porton Pharma Business Overview
Table 88. Porton Pharma Small Molecule CDMO Product
Table 89. Porton Pharma Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 90. Porton Pharma Recent Development
Table 91. ChemPartner Company Details
Table 92. ChemPartner Business Overview
Table 93. ChemPartner Small Molecule CDMO Product
Table 94. ChemPartner Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 95. ChemPartner Recent Development
Table 96. Jiangsu Sinopep Company Details
Table 97. Jiangsu Sinopep Business Overview
Table 98. Jiangsu Sinopep Small Molecule CDMO Product
Table 99. Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 100. Jiangsu Sinopep Recent Development
Table 101. DELPHARM Company Details
Table 102. DELPHARM Business Overview
Table 103. DELPHARM Small Molecule CDMO Product
Table 104. DELPHARM Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 105. DELPHARM Recent Development
Table 106. Aenova Group Company Details
Table 107. Aenova Group Business Overview
Table 108. Aenova Group Small Molecule CDMO Product
Table 109. Aenova Group Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 110. Aenova Group Recent Development
Table 111. Siegfried Holding AG Company Details
Table 112. Siegfried Holding AG Business Overview
Table 113. Siegfried Holding AG Small Molecule CDMO Product
Table 114. Siegfried Holding AG Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 115. Siegfried Holding AG Recent Development
Table 116. Recipharm AB Company Details
Table 117. Recipharm AB Business Overview
Table 118. Recipharm AB Small Molecule CDMO Product
Table 119. Recipharm AB Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 120. Recipharm AB Recent Development
Table 121. FAREVA SA Company Details
Table 122. FAREVA SA Business Overview
Table 123. FAREVA SA Small Molecule CDMO Product
Table 124. FAREVA SA Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 125. FAREVA SA Recent Development
Table 126. Almac Group Company Details
Table 127. Almac Group Business Overview
Table 128. Almac Group Small Molecule CDMO Product
Table 129. Almac Group Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 130. Almac Group Recent Development
Table 131. Cambrex Company Details
Table 132. Cambrex Business Overview
Table 133. Cambrex Small Molecule CDMO Product
Table 134. Cambrex Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 135. Cambrex Recent Development
Table 136. Charles River Company Details
Table 137. Charles River Business Overview
Table 138. Charles River Small Molecule CDMO Product
Table 139. Charles River Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 140. Charles River Recent Development
Table 141. CORDEN PHARMA Company Details
Table 142. CORDEN PHARMA Business Overview
Table 143. CORDEN PHARMA Small Molecule CDMO Product
Table 144. CORDEN PHARMA Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 145. CORDEN PHARMA Recent Development
Table 146. Jubilant Pharmova Company Details
Table 147. Jubilant Pharmova Business Overview
Table 148. Jubilant Pharmova Small Molecule CDMO Product
Table 149. Jubilant Pharmova Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 150. Jubilant Pharmova Recent Development
Table 151. Consort Medical Company Details
Table 152. Consort Medical Business Overview
Table 153. Consort Medical Small Molecule CDMO Product
Table 154. Consort Medical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 155. Consort Medical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. Small Molecule CDMO Picture
Figure 2. Global Small Molecule CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule CDMO Market Share by Type: 2024 VS 2031
Figure 4. Development Features
Figure 5. API Production Features
Figure 6. Global Small Molecule CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Molecule CDMO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Small Molecule CDMO Report Years Considered
Figure 11. Global Small Molecule CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Small Molecule CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Small Molecule CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Small Molecule CDMO Market Share by Players in 2024
Figure 15. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Small Molecule CDMO Revenue in 2024
Figure 17. North America Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Small Molecule CDMO Market Share by Country (2020-2031)
Figure 19. United States Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Small Molecule CDMO Market Share by Country (2020-2031)
Figure 23. Germany Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule CDMO Market Share by Region (2020-2031)
Figure 31. China Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Small Molecule CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 47. Catalent Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 48. Thermo Fisher Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 49. Wuxi Apptec Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 50. PharmaBlock Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 51. Asym Chemical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 52. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 53. Pharmaron Beijing Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 54. Porton Pharma Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 55. ChemPartner Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 56. Jiangsu Sinopep Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 57. DELPHARM Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 58. Aenova Group Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 59. Siegfried Holding AG Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 60. Recipharm AB Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 61. FAREVA SA Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 62. Almac Group Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 63. Cambrex Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 64. Charles River Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 65. CORDEN PHARMA Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 66. Jubilant Pharmova Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 67. Consort Medical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Small Molecule CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Development
Table 3. Key Players of API Production
Table 4. Global Small Molecule CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Molecule CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Molecule CDMO Market Share by Region (2020-2025)
Table 8. Global Small Molecule CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Molecule CDMO Market Share by Region (2026-2031)
Table 10. Small Molecule CDMO Market Trends
Table 11. Small Molecule CDMO Market Drivers
Table 12. Small Molecule CDMO Market Challenges
Table 13. Small Molecule CDMO Market Restraints
Table 14. Global Small Molecule CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Molecule CDMO Market Share by Players (2020-2025)
Table 16. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2024)
Table 17. Ranking of Global Top Small Molecule CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Molecule CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Molecule CDMO, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule CDMO, Product and Application
Table 21. Global Key Players of Small Molecule CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Molecule CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Small Molecule CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Molecule CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Small Molecule CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Molecule CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Small Molecule CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Molecule CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Molecule CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Molecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Molecule CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Molecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Molecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza Small Molecule CDMO Product
Table 49. Lonza Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Details
Table 52. Catalent Business Overview
Table 53. Catalent Small Molecule CDMO Product
Table 54. Catalent Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Thermo Fisher Company Details
Table 57. Thermo Fisher Business Overview
Table 58. Thermo Fisher Small Molecule CDMO Product
Table 59. Thermo Fisher Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Recent Development
Table 61. Wuxi Apptec Company Details
Table 62. Wuxi Apptec Business Overview
Table 63. Wuxi Apptec Small Molecule CDMO Product
Table 64. Wuxi Apptec Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 65. Wuxi Apptec Recent Development
Table 66. PharmaBlock Company Details
Table 67. PharmaBlock Business Overview
Table 68. PharmaBlock Small Molecule CDMO Product
Table 69. PharmaBlock Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 70. PharmaBlock Recent Development
Table 71. Asym Chemical Company Details
Table 72. Asym Chemical Business Overview
Table 73. Asym Chemical Small Molecule CDMO Product
Table 74. Asym Chemical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 75. Asym Chemical Recent Development
Table 76. Jiuzhou Pharmaceutical Company Details
Table 77. Jiuzhou Pharmaceutical Business Overview
Table 78. Jiuzhou Pharmaceutical Small Molecule CDMO Product
Table 79. Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 80. Jiuzhou Pharmaceutical Recent Development
Table 81. Pharmaron Beijing Company Details
Table 82. Pharmaron Beijing Business Overview
Table 83. Pharmaron Beijing Small Molecule CDMO Product
Table 84. Pharmaron Beijing Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 85. Pharmaron Beijing Recent Development
Table 86. Porton Pharma Company Details
Table 87. Porton Pharma Business Overview
Table 88. Porton Pharma Small Molecule CDMO Product
Table 89. Porton Pharma Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 90. Porton Pharma Recent Development
Table 91. ChemPartner Company Details
Table 92. ChemPartner Business Overview
Table 93. ChemPartner Small Molecule CDMO Product
Table 94. ChemPartner Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 95. ChemPartner Recent Development
Table 96. Jiangsu Sinopep Company Details
Table 97. Jiangsu Sinopep Business Overview
Table 98. Jiangsu Sinopep Small Molecule CDMO Product
Table 99. Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 100. Jiangsu Sinopep Recent Development
Table 101. DELPHARM Company Details
Table 102. DELPHARM Business Overview
Table 103. DELPHARM Small Molecule CDMO Product
Table 104. DELPHARM Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 105. DELPHARM Recent Development
Table 106. Aenova Group Company Details
Table 107. Aenova Group Business Overview
Table 108. Aenova Group Small Molecule CDMO Product
Table 109. Aenova Group Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 110. Aenova Group Recent Development
Table 111. Siegfried Holding AG Company Details
Table 112. Siegfried Holding AG Business Overview
Table 113. Siegfried Holding AG Small Molecule CDMO Product
Table 114. Siegfried Holding AG Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 115. Siegfried Holding AG Recent Development
Table 116. Recipharm AB Company Details
Table 117. Recipharm AB Business Overview
Table 118. Recipharm AB Small Molecule CDMO Product
Table 119. Recipharm AB Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 120. Recipharm AB Recent Development
Table 121. FAREVA SA Company Details
Table 122. FAREVA SA Business Overview
Table 123. FAREVA SA Small Molecule CDMO Product
Table 124. FAREVA SA Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 125. FAREVA SA Recent Development
Table 126. Almac Group Company Details
Table 127. Almac Group Business Overview
Table 128. Almac Group Small Molecule CDMO Product
Table 129. Almac Group Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 130. Almac Group Recent Development
Table 131. Cambrex Company Details
Table 132. Cambrex Business Overview
Table 133. Cambrex Small Molecule CDMO Product
Table 134. Cambrex Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 135. Cambrex Recent Development
Table 136. Charles River Company Details
Table 137. Charles River Business Overview
Table 138. Charles River Small Molecule CDMO Product
Table 139. Charles River Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 140. Charles River Recent Development
Table 141. CORDEN PHARMA Company Details
Table 142. CORDEN PHARMA Business Overview
Table 143. CORDEN PHARMA Small Molecule CDMO Product
Table 144. CORDEN PHARMA Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 145. CORDEN PHARMA Recent Development
Table 146. Jubilant Pharmova Company Details
Table 147. Jubilant Pharmova Business Overview
Table 148. Jubilant Pharmova Small Molecule CDMO Product
Table 149. Jubilant Pharmova Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 150. Jubilant Pharmova Recent Development
Table 151. Consort Medical Company Details
Table 152. Consort Medical Business Overview
Table 153. Consort Medical Small Molecule CDMO Product
Table 154. Consort Medical Revenue in Small Molecule CDMO Business (2020-2025) & (US$ Million)
Table 155. Consort Medical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. Small Molecule CDMO Picture
Figure 2. Global Small Molecule CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule CDMO Market Share by Type: 2024 VS 2031
Figure 4. Development Features
Figure 5. API Production Features
Figure 6. Global Small Molecule CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Molecule CDMO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Small Molecule CDMO Report Years Considered
Figure 11. Global Small Molecule CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Small Molecule CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Small Molecule CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Small Molecule CDMO Market Share by Players in 2024
Figure 15. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Small Molecule CDMO Revenue in 2024
Figure 17. North America Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Small Molecule CDMO Market Share by Country (2020-2031)
Figure 19. United States Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Small Molecule CDMO Market Share by Country (2020-2031)
Figure 23. Germany Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule CDMO Market Share by Region (2020-2031)
Figure 31. China Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Small Molecule CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Small Molecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 47. Catalent Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 48. Thermo Fisher Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 49. Wuxi Apptec Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 50. PharmaBlock Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 51. Asym Chemical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 52. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 53. Pharmaron Beijing Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 54. Porton Pharma Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 55. ChemPartner Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 56. Jiangsu Sinopep Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 57. DELPHARM Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 58. Aenova Group Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 59. Siegfried Holding AG Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 60. Recipharm AB Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 61. FAREVA SA Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 62. Almac Group Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 63. Cambrex Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 64. Charles River Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 65. CORDEN PHARMA Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 66. Jubilant Pharmova Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 67. Consort Medical Revenue Growth Rate in Small Molecule CDMO Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232